Navigation Links
Study offers new insights into teenagers and anxiety disorders
Date:9/15/2008

and, in particular, during sections of the safe screens and the early phase of the danger screens.

"This is interpreted as neuroticism leading to enhanced anxiety under conditions associated with aversive events but in which negative events themselves are very unlikely," Craske said. "It may represent a failure to distinguish conditions that are safe from conditions in which threatening events are very likely to occur. By translation, these findings suggest that persons with high neuroticism would respond with appropriate fear to actual threatening events, but with additional unnecessary anxiety to surrounding conditions. This type of responding may explain why neuroticism contributes to the development of pervasive anxiety."

Craske and her colleagues report their findings this month in the journal Biological Psychiatry.

She hopes the study will reveal the risk factors that predict anxiety, versus depression, and which risk factors are common to both anxiety and depression.

"Anxiety and depression often go hand in hand; we're trying to learn what factors place adolescents at risk for the development of anxiety and depression, what is common between anxiety and depression, and what is unique to each," Craske said. "We chose this age group because 16-to-19 is when anxiety and mood disorders tend to surge in prevalence."

Some 25 percent of the U.S. population experience anxiety disorders over their lifetime; these disorders are about twice as common in women as men, Craske said. If those at risk can be identified in advance, perhaps they can be treated with an early intervention, reducing the risk for later anxiety problems.

At the outset of the study, many of the teenagers were already experiencing depression and anxiety, more than Craske had expected.

"We assumed most would not be currently anxious or depressed and we would see who develops disorders over time," she said. "We we
'/>"/>

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Retrospective study analyzes expenses of osteoporosis-related fracture over 3 years
2. Later Use of Clot-Buster After Stroke Possible: Study
3. New IRC Study Documents Role of Chiropractors in Minnesotas No-Fault Auto Insurance System
4. Study Shows High Gum Disease Rates in Rural Appalachia, Sheds Light on Reasons for Tooth Loss
5. New study on rural HIV care has economic and health implications
6. CDC awards Clemson researcher $700,000 to study black lung prevention
7. Risk of breast cancer mutations underestimated for Asian women, Stanford study shows
8. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
9. National study finds post-traumatic stress disorder common among injured patients
10. UIC leads multi-center study to evaluate blood flow and stroke risk
11. Study Probes Why Smokers Find It Hard to Quit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...oosts urine production, experts say , ,...ke up during the night to urinate shouldn,t automa... breathing-related sleep disorder, could be the ca...ation, or nocturia, is comparable to loud snoring ...r in which soft tissue in the throat blocks the fl...
(Date:11/28/2009)...ider change after 30-minute psychosocial intervent...althDay News) -- A program that gets persistent dr... dangerous behavior may lead to significant and lo...he new study included 184 men and women with two o...e randomly assigned to one of two interventions. T...
(Date:11/27/2009)...plikins Ltd. today issued its latest biochemical a...that the lethality of the virus has dropped from i...nt outbreak in the spring of 2009 to resting non-e...N1 infectivity count, however, remains increased. ... 27, 2009 -- Biotech firm Replikins Ltd., which ha...
(Date:11/27/2009)...7 Shamir Optical Industr...ovider of innovative products and technology to th... board of directors had declared a dividend distri...pproximately NIS 37.62 million based on the Novemb...pproximately US$ 0.609 (approximately NIS 2.3 base...
(Date:11/27/2009)...rade; announced today that Spectrum Health (Grand ...prise orthopedic templating solution and its Traum... (PRWEB) November 27, 2009 -- Voyant Health...d Rapids, Michigan) has licensed its TraumaCad Ent...umaCad Extend workflow solution, to allow its orth...
Breaking Medicine News(10 mins):Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...loskeletal Transplant,Foundation (MTF) will provid... needed for cartilage and joint repair for injured...cilities will be given priority in obtaining,tissu...U.S. servicemen and women, many of whom have under...
...10 million to novel effort , , THURSDAY, M...e entertainment industry and Major League Baseball...ionwide initiative that will fund the brightest re...eth Berkley, Jimmy Smits, Goran Visnjic and other ...
...titutes of Health (NIH) has awarded one of 14 Clin...008 to a team based at Boston University Medical (...l Center (BMC). These awards, together with 12 CTS...inical and translational research is conducted, ul...
...n German . ,,, In Germany alone, about three m...y healing large-area wounds caused by complaints s... be treated with conventional collagen dressings o...tists at the Fraunhofer Institute for Silicate Res...
...t Karen H. Antman, MD, provost of Boston Universit...ool of Medicine, will be honored with the Distingu...he American Society of Clinical Oncology (ASCO) at...development of a standard treatment regimen for sa...
... Pennsylvania,Department of Health today urged smo...World No Tobacco Day," which is designed to raise ...xposure to secondhand smoke causes disease and pre...date for,World No Tobacco Day, and use the state,s...
Other Medicine News:Health News:Initiative Links Celebrities to Cancer Research 2Health News:Initiative Links Celebrities to Cancer Research 3Health News:BUMC, BMC receives Clinical and Translational Science Award from NIH 2Health News:Rapid wound healing 2Health News:BUMC provost, BUSM dean, to be honored at world's largest meeting of oncology professionals 2
(Date:11/27/2009)...prevent illnesses caused by subtypes A and B influ...Newswire-USNewswire/ -- The U.S. Food and Drug Adm... 18 years and older to prevent disease caused by i...ttp://www.newscom.com/cgi-bin/prnh/20090824/FDALOG...es and Diagnostics in Siena, Italy, was approved u...
(Date:11/26/2009)...Africa, Nov. 26 The 2009 Frost &am... in the Generic Pharmaceutical Market is presented...: http://www.newscom.com/cgi-bin/prnh/20081117/FS...e following criteria were used to benchmark Cipla ...th strategy and implementation, degree of innovati...
(Date:11/25/2009)...25 Hologic, Inc. (Hologi...loper, manufacturer and supplier of premium diagno...ts dedicated to serving the healthcare needs of wo...al Society of North America (RSNA) at McCormick Pl...09 to highlight our new SecurView(®) DX multi...
Breaking Medicine Technology:FDA Approves Agriflu Seasonal Influenza Vaccine 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Most Parents Worried About Bullying in U S High Schools 56990 1Most Parents Worried About Bullying in U S High Schools 56990 2Toshos Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I V Automation Strategic Partnersh 56987 1Toshos Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I V Automation Strategic Partnersh 56987 2Toshos Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I V Automation Strategic Partnersh 56987 3Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting 4979 1Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting 4979 2Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting 4979 3
...WIRE)--Mar 7, 2007 - Gemin X,announced today that ...urnal Blood demonstrated that its lead compound, G...onses against,patient-derived multiple myeloma tum...oma effects when used as a combination therapy.,GX...o inhibit all,relevant members of the Bcl-2 protei...
...at the American College of,Cardiology,s Scientific...ewswire-FirstCall/ -- CV,Therapeutics, Inc. announ...the MERLIN TIMI-36 study of ranolazine shows there...atients on ranolazine.,The study did not meet the ...e company,s special protocol assessment,agreement ...
Other Medicine Technology:Gemin X Announces Publication of Preclinical Data of GX15-070 in,Multiple Myeloma in Blood 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3
Hudson Cranial Drill
Michele Vertebral Biopsy Trephine
Greenberg Universal Retractor Case
Greenberg Secondary Bar
Medicine Products: